# US 2012/0232281 A1 · Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, an intermediate of etoricoxib

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0232281 A1
- Document ID: US20120232281A1
- Status: Published application
- Kind: A1
- Application number: 13/348,371
- Filed: 2012-01-11
- Published: 2012-09-13
- Earliest claimed: 2011-03-09
- Assignees: F.I.S. Fabbrica Italiana Sintetici S.p.A.
- Inventors: Andrea Castellin; Paolo Stabile; Francesco Fontana; Ottorino De Lucchi; Andrea Caporale; Stefano Tartaggia
- Web page: https://patentgrep.com/patent/US20120232281A1

## CPC

- C07D 213/127: Preparation from compounds containing pyridine rings
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C07D 213/50: Ketonic radicals
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A process for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methyl sulfonyl)phenyl]ethanone, an intermediate of the synthesis of Etoricoxib. The synthesis of the intermediates useful for such preparation is also described.

## Claims

### Claim 1

Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone of formula (I) or a salt thereof:
comprising the following steps:
a. the reaction of 1-(6-methylpyridin-3-yl)ethanone of formula (II):
with the 4-substituted-phenylmethyl sulfide or sulfoxide or sulfone of formula (III-bis):
wherein n is an integer comprised between 0 and 2 and X is selected from the group consisting of F, Br, Cl, I, OTs, OTf, OMs, ONE and O(C═O)NR2 where R is a linear or branched C1-C4 alkyl substituent or it is phenyl or benzyl;
b. if n is 0 or 1, comprising the further oxidation of the relative intermediate of formula (VI):
or formula (VI-bis):
to the product of formula (I).

### Claim 2 (depends on 1)

Process according to claim 1, wherein the compound of formula (III-bis) has n equal to 2, that is, has formula (III):
wherein X has the same meanings as in claim 1.

### Claim 3 (depends on 1)

Process according to claim 1, wherein X is bromine.

### Claim 4 (depends on 1)

Process according to claim 1, wherein the reaction is conducted in organic solvent selected from the group comprising toluene, xylene, alcohols, ether solvents such as dioxane and THF, Me-THF, DMF, DMSO and NMP or it is THF or NMP or DMF.

### Claim 5 (depends on 1)

Process according to claim 1, wherein the reaction is conducted in the presence of a base selected from potassium tert-butoxide and potassium phosphate.

### Claim 6 (depends on 1)

Process according to claim 1, wherein 1 to 3 molar base equivalents are used, or 3 molar base equivalents are used.

### Claim 7 (depends on 1)

Process according to claim 1, wherein the reaction is conducted in the presence of a catalytic precursor selected from Pd(OAc)2, Pd(F6-acac)2 and Pd(acac)2 or it is Pd(OAc)2.

### Claim 8 (depends on 1)

Process according to claim 1, wherein an amount from 0.05% to 2% molar of catalyst relative to the substrate of formula (II) is used in the reaction.

### Claim 9 (depends on 1)

Process according to claim 1, wherein an amount from 0.15% to 0.5% molar of catalyst relative to the substrate of formula (II) is used in the reaction.

### Claim 10 (depends on 1)

Process according to claim 1, wherein the reaction is conducted in the presence of a binding agent used for reaction, selected from the group comprising PPh3, P(Cy)3, Josiphos, Xantphos, dppe, dppp, dppf or it is Xantphos.

### Claim 11 (depends on 1)

Process according to claim 1, wherein molar amounts of ligand from 0.5 to 2 times the molar amount of Palladium catalytic precursor are used.

### Claim 12 (depends on 1)

Process according to claim 1, wherein molar amounts of ligand of about 0.5 times the molar amount of Palladium acetate catalytic precursor are used.

### Claim 13 (depends on 1)

Process according to claim 1, wherein the reaction is conducted at between 60° C. and 140° C., or at between 80° C. and 120° C.

### Claim 14 (depends on 1)

Process according to claim 1, wherein the reaction is conducted at between 85° C. and 100° C.

### Claim 15 (depends on 1)

Process according to claim 1, wherein the reaction is conducted for between 16 to 30 hours.

### Claim 16 (depends on 1)

Process according to claim 1, wherein the reaction is conducted for between 18 to 20 hours.

### Claim 17 (depends on 1)

Process according to claim 1, wherein the reaction is conducted in an anhydrous milieu.

### Claim 18 (depends on 1)

Process according to claim 1, wherein 1-(6-methylpyridin-3-yl)ethanone of formula (II):
is obtained by conversion of the intermediate 5-ethynyl-2-methylpyridine of formula (IV):

### Claim 19 (depends on 18)

Process according to claim 18, wherein the intermediate 5-ethynyl-2-methylpyridine of formula (IV):
is obtained by conversion of the intermediate 6-methylpyridin-3-yl trifluoromethansulfonate of formula (V):

### Claim 20 (depends on 1)

Process according to claim 1, wherein step a. is conducted in DMF in the presence of potassium phosphate as a base, palladium(II) acetate as a catalytic precursor and Xantphos as a ligand.

### Claim 21 (depends on 1)

Process according to claim 1, further comprising a purification step of compound 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone of formula (I) or a salt thereof:
thus obtained.

### Claim 22

Method for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone of formula (I) or a salt thereof comprising the step of using a Palladium catalyst.

### Claim 23

Method for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone of formula (I) or a salt thereof comprising the step of using Xantphos ligand.
